Login / Signup

Lessons from tofacitinib in patients with cardiovascular risk factors: increased pulmonary embolism or isolated (thrombotic) pulmonary occlusion rates?

Thomas Dörner
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • pulmonary embolism
  • cardiovascular risk factors
  • rheumatoid arthritis
  • pulmonary hypertension
  • cardiovascular disease
  • inferior vena cava
  • metabolic syndrome
  • ulcerative colitis
  • type diabetes